首页    期刊浏览 2024年09月01日 星期日
登录注册

文章基本信息

  • 标题:Costs of care for persons with opioid dependence in commercial integrated health systems
  • 本地全文:下载
  • 作者:Frances L Lynch ; Dennis McCarty ; Jennifer Mertens
  • 期刊名称:Addiction Science & Clinical Practice
  • 电子版ISSN:1940-0640
  • 出版年度:2014
  • 卷号:9
  • 期号:1
  • 页码:16
  • DOI:10.1186/1940-0640-9-16
  • 语种:English
  • 出版社:BioMed Central
  • 摘要:

    Background

    When used in general medical practices, buprenorphine is an effective treatment for opioid dependence, yet little is known about how use of buprenorphine affects the utilization and cost of health care in commercial health systems.

    Methods

    The objective of this retrospective cohort study was to examine how buprenorphine affects patterns of medical care, addiction medicine services, and costs from the health system perspective. Individuals with two or more opioid-dependence diagnoses per year, in two large health systems (System A: n = 1836; System B: n = 4204) over the time span 2007–2008 were included. Propensity scores were used to help adjust for group differences.

    Results

    Patients receiving buprenorphine plus addiction counseling had significantly lower total health care costs than patients with little or no addiction treatment (mean health care costs with buprenorphine treatment = $13,578; vs. mean health care costs with no addiction treatment = $31,055; p < .0001), while those receiving buprenorphine plus addiction counseling and those with addiction counseling only did not differ significantly in total health care costs (mean costs with counseling only: $17,017; p = .5897). In comparison to patients receiving buprenorphine plus counseling, those with little or no addiction treatment had significantly greater use of primary care (p < .001), other medical visits (p = .001), and emergency services (p = .020). Patients with counseling only (compared to patients with buprenorphine plus counseling) used less inpatient detoxification (p < .001), and had significantly more PC visits (p = .001), other medical visits (p = .005), and mental health visits (p = .002).

    Conclusions

    Buprenorphine is a viable alternative to other treatment approaches for opioid dependence in commercial integrated health systems, with total costs of health care similar to abstinence-based counseling. Patients with buprenorphine plus counseling had reduced use of general medical services compared to the alternatives.

  • 关键词:Substance abuse; Cost analysis; Health care utilization; Commercial health insurance; Parity
国家哲学社会科学文献中心版权所有